PCSS Office-Based Treatment for Opioid Use Disorders Webinar - Monday, 6/24/2019
- Registration Closed
As of the requirements to obtain the waiver, physicians without specified experience must complete not less than 8 hours of training. A total of 8 hours of training is federally mandated for physicians and a total of 24 hours of training is mandated for NPs and PAs.
The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study. An examination on the computer study must be successfully completed within 30 days of the webinar session as part of the process to obtain a waiver for prescribing buprenorphine.
Instructions on how to log on to the second half of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please note that in order to be eligible for the waiver to prescribe Buprenorphine, you must complete a total of 8 hours consisting of the live webcast session (4.25-hours) and the online self-study session and exam (3.75-hours) within 30 days of the live webcast session. The AOAAM cannot verify completion of the webinar session if less than 4.25 hours are attended. Should you not attend for the entire session, you will have to retake the entire webinar again on a different date in order to get credit. Please be aware that it is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions in order for the AOAAM to verify your attendance.The combined live webcast and online self-study training will provide the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid dependence. Physicians who complete this course will meet the training qualification under the new law. For NPs and PAs, an additional 16-hours of training will be required for waiver eligibility.
CONTINUING MEDICAL EDUCATION: This program has been approved for 4.25 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit. CME certificates will become available once all components of the training are fulfilled.
For More Information and FREE training and educational resources on Medication Assisted Treatment –Providers' Clinical Support System for Medication Assisted Treatment (PCSS-MAT) visit www.pcssnow.org.
PCSS is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in partnership with the: American Osteopathic Academy of Addiction Medicine (AOAAM); Addiction Technology Transfer Center (ATTC); American Academy of Family Physicians (AAFP); American Academy of Neurology (AAN); American Academy of Pain Medicine (AAPM); American Academy of Pediatrics (AAP); American College of Emergency Physicians (ACEP); American College of Physicians (ACP); American Dental Association (ADA); American Medical Association (AMA); American Psychiatric Association (APA); American Psychiatric Nurses Association (APNA); American Society of Addiction Medicine (ASAM); American Society for Pain Management Nursing (ASPMN); Association for Medical Education and Research in Substance Abuse (AMERSA); International Nurses Society on Addictions (IntNSA); National Association of Community Health Centers (NACHC); National Association of Drug Court Professionals (NADCP), and the Southeast Consortium for Substance Abuse Training (SECSAT).
Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
William Morrone, DO, MS, MPH, DABAM, FACOFP, DAAPM
Medical Director at Recovery Pathways, principal investigator in a naloxone distribution for Mid-Michigan, Medical Director of 35th Circuit Shiawassee County Drug Court
Associate Professor of Family and Community Medicine, Michigan State University for 18 years and was Asst. Program Director of Family Medicine at Synergy Medical Education Alliance and liaison in the Department of Psychiatry. He has presented or published in:
Journal of Addictive Diseases (2015 and 2016), American Journal of Addiction (2013), Substance Abuse (2013), BridgeMI.com 2016-2018 (journalism co-op for setting policy), FoxNews.com (editorial) and CNN.com (news), Weekly medical columns in the Gladwin Record and Courier.
MLive.com, NPR, Arizona Public Radio, American Public Radio and Michigan Public Radio, Adolescent Addiction from the Conrad Hilton Foundation, CORE REMS as a charter master faculty PCSS monthly training sponsored by SAMHSA/CSAT for 9 yr, MOA/MAOFP news letters; AOA publications & advocacy to recognize addiction medicine
Dr. Morrone has published a naloxone book for families. AMERICAN NARCAN (2017) www.AmericanNarcan.com
He is triple board certified by the American Board of Addiction Medicine, American College of Osteopathic Family Practitioners and the American Academy of Pain Management. Dr. Morrone was a Ruth Fox faculty for the 42nd ASAM 2011 Medical-Scientific Conference Washington DC and is an active addiction educator and social advocate in pain management.
Nationally and locally he has contributed numerous didactic pieces on opiates, cannabis dependence, primary care, NAS, state based medical marijuana, non-narcotic pain management to providers in recovery; to the state medical and national societies in this area. He is Deputy Medical Director to the Bay County Health Department and principal investigator on Bay County Heroin Task Force.
He also holds a graduate degree in toxicology and pharmacology from the University of Missouri at Kansas City, graduate school of pharmacy. He also completed an MPH in Baltimore, MD.
Most notable to pop culture cable TV news viewers is that he has been on Dr. Drew-HLN, CNN News Room, Nancy Grace-CNN Headline News, Court TV, CNN, Studio “B” FOXNews Channel and MSNBC giving medical opinions on drug addiction or death and the 6 stages of decomposition. For international overdose awareness day (IOAD) he appeared on 23 TV stations in one day.
Public service is no stranger to Dr. Morrone as he is a Deputy Chief Medical Examiner, a Diplomat of American College of Forensic Examiners and has been a volunteer firefighter. Dr. Morrone is an aggressive advocate for substance abuse treatment and overdose prevention at the FDA, HHS, SAMHSA and congress. He also trained at the Armed Forces Institute of Pathology (AFIP) in Maryland.
Spent 10 years as Medical Director at Hospice of Michigan, leaving hospice to do addiction full time. Dr. Morrone is a graduate of MSU, served his internship in internal medicine in Lansing at Ingham Regional Medical Center and his residency in family medicine at the Michigan State University statewide campus site at Bay Regional Medical Center. http://wwwAmericanNarcan.com.
This program has been approved for 4.25 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit.
CME certificates will be provided within 30 days after the training date.